

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.20786029 |
| 2 | GDP-mannose metabolic process (GO:0019673) | 4.96591530 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.93834544 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.84716073 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.84716073 |
| 6 | protein maturation by protein folding (GO:0022417) | 4.70264881 |
| 7 | protein complex disassembly (GO:0043241) | 4.56469481 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 4.51534105 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.51534105 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.49696287 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 4.49696287 |
| 12 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.35187592 |
| 13 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.30924869 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 4.29799684 |
| 15 | macromolecular complex disassembly (GO:0032984) | 4.25060452 |
| 16 | protein targeting to membrane (GO:0006612) | 4.23273168 |
| 17 | chaperone-mediated protein transport (GO:0072321) | 4.12668208 |
| 18 | ribosomal large subunit biogenesis (GO:0042273) | 4.07696791 |
| 19 | aldehyde catabolic process (GO:0046185) | 4.03924692 |
| 20 | translation (GO:0006412) | 4.00462002 |
| 21 | cysteine metabolic process (GO:0006534) | 3.98832439 |
| 22 | respiratory electron transport chain (GO:0022904) | 3.97795268 |
| 23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.94946314 |
| 24 | glyoxylate metabolic process (GO:0046487) | 3.91780348 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 3.88363151 |
| 26 | electron transport chain (GO:0022900) | 3.88342564 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 3.84737380 |
| 28 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.74011711 |
| 29 | viral transcription (GO:0019083) | 3.61435045 |
| 30 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.59072265 |
| 31 | oxidative phosphorylation (GO:0006119) | 3.55134106 |
| 32 | protein targeting to mitochondrion (GO:0006626) | 3.48992743 |
| 33 | lysine metabolic process (GO:0006553) | 3.48690503 |
| 34 | lysine catabolic process (GO:0006554) | 3.48690503 |
| 35 | translational termination (GO:0006415) | 3.46240255 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.41767761 |
| 37 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.40995896 |
| 38 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.39942133 |
| 39 | bile acid and bile salt transport (GO:0015721) | 3.37259030 |
| 40 | establishment of protein localization to membrane (GO:0090150) | 3.32447926 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 3.32261118 |
| 42 | establishment of protein localization to mitochondrion (GO:0072655) | 3.31280998 |
| 43 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.27519728 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 3.27403247 |
| 45 | GTP biosynthetic process (GO:0006183) | 3.26859799 |
| 46 | tryptophan catabolic process (GO:0006569) | 3.26752059 |
| 47 | indole-containing compound catabolic process (GO:0042436) | 3.26752059 |
| 48 | indolalkylamine catabolic process (GO:0046218) | 3.26752059 |
| 49 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.25759457 |
| 50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.25759457 |
| 51 | serine family amino acid catabolic process (GO:0009071) | 3.24473036 |
| 52 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.23732119 |
| 53 | glycine metabolic process (GO:0006544) | 3.22862183 |
| 54 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.20874308 |
| 55 | cellular component biogenesis (GO:0044085) | 3.20676285 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 3.20024951 |
| 57 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.19016550 |
| 58 | serine family amino acid biosynthetic process (GO:0009070) | 3.16804759 |
| 59 | aromatic amino acid family metabolic process (GO:0009072) | 3.15893281 |
| 60 | UTP biosynthetic process (GO:0006228) | 3.15494103 |
| 61 | protein targeting to ER (GO:0045047) | 3.14792526 |
| 62 | regulation of mitochondrial translation (GO:0070129) | 3.14611621 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 3.14568533 |
| 64 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.14387378 |
| 65 | homocysteine metabolic process (GO:0050667) | 3.13832864 |
| 66 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.12710629 |
| 67 | bile acid biosynthetic process (GO:0006699) | 3.12034160 |
| 68 | formation of translation preinitiation complex (GO:0001731) | 3.11486124 |
| 69 | cotranslational protein targeting to membrane (GO:0006613) | 3.11152659 |
| 70 | translational elongation (GO:0006414) | 3.11126092 |
| 71 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.10978449 |
| 72 | DNA deamination (GO:0045006) | 3.10270401 |
| 73 | protein retention in ER lumen (GO:0006621) | 3.09401344 |
| 74 | high-density lipoprotein particle remodeling (GO:0034375) | 3.08506139 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.07359167 |
| 76 | ribosomal small subunit biogenesis (GO:0042274) | 3.06288495 |
| 77 | intestinal cholesterol absorption (GO:0030299) | 3.04700590 |
| 78 | protein localization to endoplasmic reticulum (GO:0070972) | 3.04427218 |
| 79 | Golgi transport vesicle coating (GO:0048200) | 3.03301275 |
| 80 | COPI coating of Golgi vesicle (GO:0048205) | 3.03301275 |
| 81 | proline biosynthetic process (GO:0006561) | 3.03251082 |
| 82 | viral protein processing (GO:0019082) | 3.03184313 |
| 83 | protein localization to mitochondrion (GO:0070585) | 3.01803746 |
| 84 | mRNA catabolic process (GO:0006402) | 2.99855746 |
| 85 | protein targeting (GO:0006605) | 2.99257438 |
| 86 | phospholipid efflux (GO:0033700) | 2.98254402 |
| 87 | tryptophan metabolic process (GO:0006568) | 2.98119557 |
| 88 | nucleotide salvage (GO:0043173) | 2.95955257 |
| 89 | amino-acid betaine metabolic process (GO:0006577) | 2.94705301 |
| 90 | ribosomal small subunit assembly (GO:0000028) | 2.94604915 |
| 91 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.94436375 |
| 92 | pentose metabolic process (GO:0019321) | 2.91352080 |
| 93 | alpha-linolenic acid metabolic process (GO:0036109) | 2.90985435 |
| 94 | protein complex biogenesis (GO:0070271) | 2.89204690 |
| 95 | negative regulation of fibrinolysis (GO:0051918) | 2.87744854 |
| 96 | CTP metabolic process (GO:0046036) | 2.87001213 |
| 97 | CTP biosynthetic process (GO:0006241) | 2.87001213 |
| 98 | fatty acid beta-oxidation (GO:0006635) | 2.85868948 |
| 99 | cofactor catabolic process (GO:0051187) | 2.85566680 |
| 100 | deoxyribonucleotide catabolic process (GO:0009264) | 2.83536532 |
| 101 | alpha-amino acid catabolic process (GO:1901606) | 2.83434165 |
| 102 | viral life cycle (GO:0019058) | 2.83271787 |
| 103 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.83037898 |
| 104 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.82049731 |
| 105 | UTP metabolic process (GO:0046051) | 2.81895406 |
| 106 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.81007021 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 2.80476129 |
| 108 | protein-lipid complex remodeling (GO:0034368) | 2.80476129 |
| 109 | macromolecular complex remodeling (GO:0034367) | 2.80476129 |
| 110 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.80198576 |
| 111 | virion assembly (GO:0019068) | 2.80156029 |
| 112 | aspartate family amino acid catabolic process (GO:0009068) | 2.80027859 |
| 113 | nucleoside salvage (GO:0043174) | 2.79712990 |
| 114 | protein carboxylation (GO:0018214) | 2.79254480 |
| 115 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.79254480 |
| 116 | ATP biosynthetic process (GO:0006754) | 2.79196566 |
| 117 | urea metabolic process (GO:0019627) | 2.78612369 |
| 118 | urea cycle (GO:0000050) | 2.78612369 |
| 119 | flavonoid metabolic process (GO:0009812) | 2.78316096 |
| 120 | negative regulation of cholesterol transport (GO:0032375) | 2.78019207 |
| 121 | negative regulation of sterol transport (GO:0032372) | 2.78019207 |
| 122 | hydrogen ion transmembrane transport (GO:1902600) | 2.77432522 |
| 123 | glucuronate metabolic process (GO:0019585) | 2.76779236 |
| 124 | uronic acid metabolic process (GO:0006063) | 2.76779236 |
| 125 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76446131 |
| 126 | heme transport (GO:0015886) | 2.76406782 |
| 127 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.75795221 |
| 128 | plasma lipoprotein particle clearance (GO:0034381) | 2.75373668 |
| 129 | L-serine metabolic process (GO:0006563) | 2.74856165 |
| 130 | NADH metabolic process (GO:0006734) | 2.74367665 |
| 131 | 2-oxoglutarate metabolic process (GO:0006103) | 2.74173808 |
| 132 | cellular amino acid catabolic process (GO:0009063) | 2.74132006 |
| 133 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.73959312 |
| 134 | nitrogen cycle metabolic process (GO:0071941) | 2.73829523 |
| 135 | fatty acid catabolic process (GO:0009062) | 2.72962836 |
| 136 | RNA catabolic process (GO:0006401) | 2.72866823 |
| 137 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.72752422 |
| 138 | protein insertion into membrane (GO:0051205) | 2.71982583 |
| 139 | ketone body metabolic process (GO:1902224) | 2.71764867 |
| 140 | cellular glucuronidation (GO:0052695) | 2.71678910 |
| 141 | acetyl-CoA metabolic process (GO:0006084) | 2.71597551 |
| 142 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.69908226 |
| 143 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.69908226 |
| 144 | mitochondrial transport (GO:0006839) | 2.69874580 |
| 145 | regulation of protein activation cascade (GO:2000257) | 2.69717100 |
| 146 | regulation of cholesterol metabolic process (GO:0090181) | 2.69633449 |
| 147 | cellular protein complex disassembly (GO:0043624) | 2.68830687 |
| 148 | aerobic respiration (GO:0009060) | 2.68330080 |
| 149 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.67438399 |
| 150 | termination of RNA polymerase III transcription (GO:0006386) | 2.67438399 |
| 151 | deoxyribose phosphate catabolic process (GO:0046386) | 2.66582923 |
| 152 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.65970480 |
| 153 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.65970480 |
| 154 | NADH dehydrogenase complex assembly (GO:0010257) | 2.65970480 |
| 155 | nuclear envelope reassembly (GO:0031468) | 2.65542693 |
| 156 | mitotic nuclear envelope reassembly (GO:0007084) | 2.65542693 |
| 157 | monocarboxylic acid catabolic process (GO:0072329) | 2.64438558 |
| 158 | triglyceride homeostasis (GO:0070328) | 2.64358017 |
| 159 | acylglycerol homeostasis (GO:0055090) | 2.64358017 |
| 160 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.63882890 |
| 161 | bile acid metabolic process (GO:0008206) | 2.63727850 |
| 162 | translational initiation (GO:0006413) | 2.63611436 |
| 163 | benzene-containing compound metabolic process (GO:0042537) | 2.63482423 |
| 164 | regulation of fibrinolysis (GO:0051917) | 2.63445185 |
| 165 | heme metabolic process (GO:0042168) | 2.62962723 |
| 166 | organic acid catabolic process (GO:0016054) | 2.62768463 |
| 167 | carboxylic acid catabolic process (GO:0046395) | 2.62768463 |
| 168 | reverse cholesterol transport (GO:0043691) | 2.62557275 |
| 169 | protein localization to membrane (GO:0072657) | 2.62075395 |
| 170 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.59838964 |
| 171 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.59754844 |
| 172 | UV protection (GO:0009650) | 2.59691713 |
| 173 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.58505419 |
| 174 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.58065196 |
| 175 | negative regulation of ligase activity (GO:0051352) | 2.55745277 |
| 176 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.55745277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.67145100 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.39604968 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68972503 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.57443174 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.54694804 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.01451644 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.57700944 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40676849 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.38519851 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.34879425 |
| 11 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.31038878 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.23387235 |
| 13 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.18260530 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17280194 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.17213981 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.15087092 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.11440775 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.09050892 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.07645472 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97490283 |
| 21 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95895043 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.94295765 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.88803462 |
| 24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.87779356 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.80553972 |
| 26 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.78951917 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70793897 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68046546 |
| 29 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.64658684 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63507324 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57017169 |
| 32 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.56038814 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53907973 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.53296319 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52946035 |
| 36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52330804 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51262479 |
| 38 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.50896295 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49798192 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.45278249 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.42800290 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42347080 |
| 43 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.40466815 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.38290365 |
| 45 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.36628310 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34922352 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34595110 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.30466092 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27969032 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27918018 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27610028 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.27592515 |
| 53 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.27102668 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27098645 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26504366 |
| 56 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.25923488 |
| 57 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.25797547 |
| 58 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.25470691 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.25216147 |
| 60 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23871272 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23334542 |
| 62 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22943324 |
| 63 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22823604 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21111709 |
| 65 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21042199 |
| 66 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.20478856 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19176657 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17338132 |
| 69 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.16364556 |
| 70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15794653 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15587471 |
| 72 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.13339900 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13137441 |
| 74 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12808104 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10221099 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09535795 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09356902 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08687484 |
| 79 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08371365 |
| 80 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.07975426 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07886273 |
| 82 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.07410284 |
| 83 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06558630 |
| 84 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06463046 |
| 85 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05810561 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05616682 |
| 87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.04584145 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03697875 |
| 89 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03285738 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03283904 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03128773 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01679419 |
| 93 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01474692 |
| 94 | * MAF_26560356_Chip-Seq_TH2_Human | 1.01359680 |
| 95 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.01315117 |
| 96 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.00757828 |
| 97 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00396980 |
| 98 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.99858508 |
| 99 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99568689 |
| 100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99070119 |
| 101 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98931765 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98661733 |
| 103 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98246490 |
| 104 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97977013 |
| 105 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97311685 |
| 106 | * CLOCK_20551151_ChIP-Seq_293T_Human | 0.97078105 |
| 107 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96543387 |
| 108 | * P68_20966046_ChIP-Seq_HELA_Human | 0.95890501 |
| 109 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95869960 |
| 110 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95638163 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95108063 |
| 112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93932071 |
| 113 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93854954 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.93829303 |
| 115 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93368486 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93188101 |
| 117 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.93162339 |
| 118 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.92780097 |
| 119 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92042213 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91867550 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91398153 |
| 122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91216700 |
| 123 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.89134151 |
| 124 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88999692 |
| 125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88912730 |
| 126 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.87817670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.71341200 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.50779723 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.62841376 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.21487336 |
| 5 | MP0005365_abnormal_bile_salt | 3.78681069 |
| 6 | MP0009840_abnormal_foam_cell | 3.78158185 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.52458777 |
| 8 | MP0005083_abnormal_biliary_tract | 3.34650116 |
| 9 | MP0004858_abnormal_nervous_system | 2.89092990 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.76473798 |
| 11 | MP0003186_abnormal_redox_activity | 2.60121138 |
| 12 | MP0005332_abnormal_amino_acid | 2.55445871 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.45998242 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.35747823 |
| 15 | MP0003252_abnormal_bile_duct | 2.17219486 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.16134383 |
| 17 | MP0003123_paternal_imprinting | 2.06967419 |
| 18 | MP0003195_calcinosis | 2.04932825 |
| 19 | MP0000678_abnormal_parathyroid_gland | 2.02982952 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.95379586 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.90883037 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.90313334 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.87750433 |
| 24 | MP0003879_abnormal_hair_cell | 1.76872675 |
| 25 | MP0005451_abnormal_body_composition | 1.75885882 |
| 26 | MP0008260_abnormal_autophagy | 1.75454172 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.73907790 |
| 28 | MP0000609_abnormal_liver_physiology | 1.62280966 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62111858 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.57104421 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.56471580 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.53835470 |
| 33 | MP0001764_abnormal_homeostasis | 1.50246193 |
| 34 | MP0003075_altered_response_to | 1.48945413 |
| 35 | MP0000490_abnormal_crypts_of | 1.46838075 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.43287335 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.39896229 |
| 38 | MP0009785_altered_susceptibility_to | 1.39779571 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.39557298 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.37776404 |
| 41 | MP0000681_abnormal_thyroid_gland | 1.31748338 |
| 42 | MP0008469_abnormal_protein_level | 1.30294239 |
| 43 | MP0003436_decreased_susceptibility_to | 1.30084404 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.27555452 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.27101810 |
| 46 | MP0001756_abnormal_urination | 1.26358123 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.18089370 |
| 48 | MP0002249_abnormal_larynx_morphology | 1.17923570 |
| 49 | MP0010234_abnormal_vibrissa_follicle | 1.17095921 |
| 50 | MP0002822_catalepsy | 1.11984098 |
| 51 | MP0001905_abnormal_dopamine_level | 1.08320623 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.08290877 |
| 53 | MP0003724_increased_susceptibility_to | 1.04995291 |
| 54 | MP0004957_abnormal_blastocyst_morpholog | 1.04833254 |
| 55 | MP0000598_abnormal_liver_morphology | 1.04712551 |
| 56 | MP0009764_decreased_sensitivity_to | 1.02924816 |
| 57 | MP0000685_abnormal_immune_system | 1.02296879 |
| 58 | MP0003011_delayed_dark_adaptation | 1.00672549 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.00399969 |
| 60 | MP0005025_abnormal_response_to | 1.00030692 |
| 61 | MP0005670_abnormal_white_adipose | 0.99043199 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 0.99027507 |
| 63 | MP0001853_heart_inflammation | 0.97602528 |
| 64 | MP0002136_abnormal_kidney_physiology | 0.95131416 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 0.95070052 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 0.95051201 |
| 67 | MP0006082_CNS_inflammation | 0.93985376 |
| 68 | MP0002132_abnormal_respiratory_system | 0.93757230 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 0.93534161 |
| 70 | MP0002796_impaired_skin_barrier | 0.93110759 |
| 71 | MP0005330_cardiomyopathy | 0.91820703 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.91022000 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.90996542 |
| 74 | MP0000750_abnormal_muscle_regeneration | 0.90241913 |
| 75 | MP0008438_abnormal_cutaneous_collagen | 0.90125764 |
| 76 | MP0005266_abnormal_metabolism | 0.89350579 |
| 77 | MP0003646_muscle_fatigue | 0.88341757 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.88162720 |
| 79 | MP0000604_amyloidosis | 0.87993809 |
| 80 | MP0003866_abnormal_defecation | 0.87983204 |
| 81 | MP0004947_skin_inflammation | 0.87198373 |
| 82 | MP0005376_homeostasis/metabolism_phenot | 0.86515858 |
| 83 | MP0001835_abnormal_antigen_presentation | 0.85983770 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.85334423 |
| 85 | MP0001849_ear_inflammation | 0.85203473 |
| 86 | MP0000358_abnormal_cell_content/ | 0.84755795 |
| 87 | MP0001727_abnormal_embryo_implantation | 0.84137249 |
| 88 | MP0005257_abnormal_intraocular_pressure | 0.83962268 |
| 89 | MP0000747_muscle_weakness | 0.83715223 |
| 90 | MP0004043_abnormal_pH_regulation | 0.83087480 |
| 91 | MP0002163_abnormal_gland_morphology | 0.80044520 |
| 92 | MP0003693_abnormal_embryo_hatching | 0.79263244 |
| 93 | MP0003638_abnormal_response/metabolism_ | 0.78690813 |
| 94 | MP0009763_increased_sensitivity_to | 0.78575615 |
| 95 | MP0004233_abnormal_muscle_weight | 0.78268458 |
| 96 | MP0005165_increased_susceptibility_to | 0.78105415 |
| 97 | MP0001881_abnormal_mammary_gland | 0.78044116 |
| 98 | MP0008874_decreased_physiological_sensi | 0.77356508 |
| 99 | MP0004510_myositis | 0.76814831 |
| 100 | MP0008932_abnormal_embryonic_tissue | 0.76057783 |
| 101 | MP0000538_abnormal_urinary_bladder | 0.75887971 |
| 102 | MP0004782_abnormal_surfactant_physiolog | 0.74079352 |
| 103 | MP0001663_abnormal_digestive_system | 0.73169589 |
| 104 | MP0005535_abnormal_body_temperature | 0.72872625 |
| 105 | MP0000343_altered_response_to | 0.72028215 |
| 106 | MP0008873_increased_physiological_sensi | 0.71409199 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.70291271 |
| 108 | MP0009278_abnormal_bone_marrow | 0.69357045 |
| 109 | MP0005166_decreased_susceptibility_to | 0.69167369 |
| 110 | MP0000313_abnormal_cell_death | 0.67859892 |
| 111 | MP0000749_muscle_degeneration | 0.67562917 |
| 112 | MP0008872_abnormal_physiological_respon | 0.66720265 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.66681800 |
| 114 | MP0003718_maternal_effect | 0.66100755 |
| 115 | MP0005023_abnormal_wound_healing | 0.65866690 |
| 116 | MP0003786_premature_aging | 0.65247578 |
| 117 | MP0005375_adipose_tissue_phenotype | 0.64873398 |
| 118 | MP0002269_muscular_atrophy | 0.63635735 |
| 119 | MP0003868_abnormal_feces_composition | 0.63504305 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.63473788 |
| 121 | MP0005377_hearing/vestibular/ear_phenot | 0.63136291 |
| 122 | MP0003878_abnormal_ear_physiology | 0.63136291 |
| 123 | MP0000858_altered_metastatic_potential | 0.61889813 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61337593 |
| 125 | MP0003315_abnormal_perineum_morphology | 0.61125531 |
| 126 | MP0003329_amyloid_beta_deposits | 0.60688249 |
| 127 | MP0000537_abnormal_urethra_morphology | 0.59450359 |
| 128 | MP0000477_abnormal_intestine_morphology | 0.58512262 |
| 129 | MP0001542_abnormal_bone_strength | 0.58339656 |
| 130 | MP0010771_integument_phenotype | 0.57208950 |
| 131 | MP0000249_abnormal_blood_vessel | 0.57022614 |
| 132 | MP0005408_hypopigmentation | 0.56866119 |
| 133 | MP0005501_abnormal_skin_physiology | 0.56832349 |
| 134 | MP0001243_abnormal_dermal_layer | 0.56673694 |
| 135 | MP0001873_stomach_inflammation | 0.56270686 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.56119704 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.56107888 |
| 138 | MP0005381_digestive/alimentary_phenotyp | 0.55811645 |
| 139 | MP0001765_abnormal_ion_homeostasis | 0.55667847 |
| 140 | MP0004084_abnormal_cardiac_muscle | 0.55448161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.88104667 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.96763880 |
| 3 | Reticulocytopenia (HP:0001896) | 3.95353354 |
| 4 | Xanthomatosis (HP:0000991) | 3.81218679 |
| 5 | Acute encephalopathy (HP:0006846) | 3.73532424 |
| 6 | Hepatic necrosis (HP:0002605) | 3.73405866 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 3.72994246 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.65009694 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.55282830 |
| 10 | Cerebral edema (HP:0002181) | 3.53116306 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.48679414 |
| 12 | Mitochondrial inheritance (HP:0001427) | 3.41628924 |
| 13 | Hyperammonemia (HP:0001987) | 3.41032780 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.38536444 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32168322 |
| 16 | Deep venous thrombosis (HP:0002625) | 3.29901753 |
| 17 | Hyperglycinuria (HP:0003108) | 3.23870482 |
| 18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.16098783 |
| 19 | Dicarboxylic aciduria (HP:0003215) | 3.16098783 |
| 20 | Lethargy (HP:0001254) | 3.08576925 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.07128177 |
| 22 | Increased CSF lactate (HP:0002490) | 3.06535616 |
| 23 | Vertebral compression fractures (HP:0002953) | 3.04232134 |
| 24 | Increased muscle lipid content (HP:0009058) | 3.01261999 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 2.97831501 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.92670793 |
| 27 | Hypoglycemic coma (HP:0001325) | 2.92284410 |
| 28 | Ragged-red muscle fibers (HP:0003200) | 2.91884112 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 2.90469746 |
| 30 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.88553837 |
| 31 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.88553837 |
| 32 | Hyperglycinemia (HP:0002154) | 2.85838647 |
| 33 | Prolonged partial thromboplastin time (HP:0003645) | 2.84385329 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 2.83261408 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.83261408 |
| 36 | Ketosis (HP:0001946) | 2.82869161 |
| 37 | Progressive macrocephaly (HP:0004481) | 2.81793016 |
| 38 | Achilles tendon contracture (HP:0001771) | 2.80568500 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.79243248 |
| 40 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.78457512 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.78373695 |
| 42 | Hypolipoproteinemia (HP:0010981) | 2.76309833 |
| 43 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.74720610 |
| 44 | Lactic acidosis (HP:0003128) | 2.74456134 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.71364320 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 2.70425969 |
| 47 | Glycosuria (HP:0003076) | 2.70425969 |
| 48 | Gout (HP:0001997) | 2.69815207 |
| 49 | Multiple enchondromatosis (HP:0005701) | 2.68269571 |
| 50 | Nausea (HP:0002018) | 2.67062272 |
| 51 | Malnutrition (HP:0004395) | 2.66842115 |
| 52 | Fat malabsorption (HP:0002630) | 2.61869816 |
| 53 | Abnormality of the Achilles tendon (HP:0005109) | 2.60561590 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58193602 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58193602 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58193602 |
| 57 | Microretrognathia (HP:0000308) | 2.56269667 |
| 58 | Increased hepatocellular lipid droplets (HP:0006565) | 2.55156997 |
| 59 | Vomiting (HP:0002013) | 2.50797123 |
| 60 | Myokymia (HP:0002411) | 2.49917468 |
| 61 | Rough bone trabeculation (HP:0100670) | 2.49245136 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.47762248 |
| 63 | Emotional lability (HP:0000712) | 2.47504513 |
| 64 | Abnormal number of erythroid precursors (HP:0012131) | 2.44692825 |
| 65 | Pallor (HP:0000980) | 2.44173409 |
| 66 | Rhabdomyolysis (HP:0003201) | 2.43328356 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.42568481 |
| 68 | Distal lower limb muscle weakness (HP:0009053) | 2.42362737 |
| 69 | Respiratory failure (HP:0002878) | 2.41738794 |
| 70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.41221606 |
| 71 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.40768849 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.40760442 |
| 73 | Metabolic acidosis (HP:0001942) | 2.39199859 |
| 74 | Increased serum lactate (HP:0002151) | 2.38585356 |
| 75 | Ketoacidosis (HP:0001993) | 2.37310011 |
| 76 | Myopathic facies (HP:0002058) | 2.34140127 |
| 77 | Hyperparathyroidism (HP:0000843) | 2.33359393 |
| 78 | Testicular atrophy (HP:0000029) | 2.33349272 |
| 79 | Abnormality of nucleobase metabolism (HP:0010932) | 2.32803767 |
| 80 | Abnormal cartilage morphology (HP:0002763) | 2.32555992 |
| 81 | Ileus (HP:0002595) | 2.32090228 |
| 82 | Hyperbilirubinemia (HP:0002904) | 2.31948122 |
| 83 | Renal Fanconi syndrome (HP:0001994) | 2.31391001 |
| 84 | Proximal tubulopathy (HP:0000114) | 2.30659175 |
| 85 | Late onset (HP:0003584) | 2.28495149 |
| 86 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.27245814 |
| 87 | Respiratory difficulties (HP:0002880) | 2.25707152 |
| 88 | Hypoalphalipoproteinemia (HP:0003233) | 2.25432822 |
| 89 | Polycythemia (HP:0001901) | 2.25086692 |
| 90 | Increased serum pyruvate (HP:0003542) | 2.24951722 |
| 91 | Abnormality of glycolysis (HP:0004366) | 2.24951722 |
| 92 | Cholecystitis (HP:0001082) | 2.24417768 |
| 93 | Abnormal gallbladder physiology (HP:0012438) | 2.24417768 |
| 94 | Myoglobinuria (HP:0002913) | 2.22423173 |
| 95 | Delayed CNS myelination (HP:0002188) | 2.19832171 |
| 96 | Prolonged neonatal jaundice (HP:0006579) | 2.19531573 |
| 97 | CNS demyelination (HP:0007305) | 2.19070581 |
| 98 | Bulbar palsy (HP:0001283) | 2.18147597 |
| 99 | Complement deficiency (HP:0004431) | 2.17393636 |
| 100 | Spastic paraparesis (HP:0002313) | 2.14923219 |
| 101 | Microvesicular hepatic steatosis (HP:0001414) | 2.14217113 |
| 102 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.13274339 |
| 103 | Systemic lupus erythematosus (HP:0002725) | 2.13044210 |
| 104 | Steatorrhea (HP:0002570) | 2.12126078 |
| 105 | Trismus (HP:0000211) | 2.11151487 |
| 106 | Hypertensive crisis (HP:0100735) | 2.11028731 |
| 107 | Redundant skin (HP:0001582) | 2.10799660 |
| 108 | Hypokinesia (HP:0002375) | 2.09973670 |
| 109 | Exercise intolerance (HP:0003546) | 2.09327258 |
| 110 | Macrocytic anemia (HP:0001972) | 2.08604538 |
| 111 | Progressive muscle weakness (HP:0003323) | 2.08466217 |
| 112 | Vacuolated lymphocytes (HP:0001922) | 2.07192528 |
| 113 | 3-Methylglutaconic aciduria (HP:0003535) | 2.07079730 |
| 114 | Hyperthyroidism (HP:0000836) | 2.06348174 |
| 115 | Axonal loss (HP:0003447) | 2.06287622 |
| 116 | Cholelithiasis (HP:0001081) | 2.05355103 |
| 117 | Abnormality of complement system (HP:0005339) | 2.05164199 |
| 118 | Abnormality of methionine metabolism (HP:0010901) | 2.04060523 |
| 119 | Exertional dyspnea (HP:0002875) | 2.02990734 |
| 120 | Abnormality of serum amino acid levels (HP:0003112) | 2.02799069 |
| 121 | Cerebral palsy (HP:0100021) | 2.01512507 |
| 122 | Opisthotonus (HP:0002179) | 2.00820865 |
| 123 | Leukodystrophy (HP:0002415) | 2.00079892 |
| 124 | Broad distal phalanx of finger (HP:0009836) | 1.99674836 |
| 125 | Abnormality of the common coagulation pathway (HP:0010990) | 1.98560411 |
| 126 | Increased serum ferritin (HP:0003281) | 1.98155610 |
| 127 | Abnormal trabecular bone morphology (HP:0100671) | 1.97523431 |
| 128 | Palpitations (HP:0001962) | 1.96697420 |
| 129 | Abnormal gallbladder morphology (HP:0012437) | 1.95275192 |
| 130 | Pancreatitis (HP:0001733) | 1.93293252 |
| 131 | Abnormality of reticulocytes (HP:0004312) | 1.91427862 |
| 132 | Abnormal hemoglobin (HP:0011902) | 1.90407233 |
| 133 | Right ventricular cardiomyopathy (HP:0011663) | 1.89864974 |
| 134 | Methylmalonic aciduria (HP:0012120) | 1.89020220 |
| 135 | Increased cerebral lipofuscin (HP:0011813) | 1.88962086 |
| 136 | Growth hormone excess (HP:0000845) | 1.88256035 |
| 137 | Premature skin wrinkling (HP:0100678) | 1.86897959 |
| 138 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84926511 |
| 139 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82950818 |
| 140 | Cerebral hypomyelination (HP:0006808) | 1.82266498 |
| 141 | Purpura (HP:0000979) | 1.79531278 |
| 142 | Type I transferrin isoform profile (HP:0003642) | 1.77689768 |
| 143 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.75973311 |
| 144 | Distal upper limb amyotrophy (HP:0007149) | 1.73096715 |
| 145 | Upper limb amyotrophy (HP:0009129) | 1.73096715 |
| 146 | Polygenic inheritance (HP:0010982) | 1.72827485 |
| 147 | Abnormality of the nasal mucosa (HP:0000433) | 1.72555454 |
| 148 | Stridor (HP:0010307) | 1.70962286 |
| 149 | Abnormal urine phosphate concentration (HP:0012599) | 1.70901835 |
| 150 | Optic disc pallor (HP:0000543) | 1.69170496 |
| 151 | Truncus arteriosus (HP:0001660) | 1.67399679 |
| 152 | Chronic obstructive pulmonary disease (HP:0006510) | 1.67088692 |
| 153 | Obstructive lung disease (HP:0006536) | 1.67088692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.74984244 |
| 2 | BCKDK | 4.52279615 |
| 3 | NME2 | 4.49677295 |
| 4 | SMG1 | 3.53610369 |
| 5 | ERN1 | 3.32007219 |
| 6 | PIM2 | 3.07021426 |
| 7 | TBK1 | 2.82221504 |
| 8 | ARAF | 2.78884908 |
| 9 | MAP3K11 | 2.70979274 |
| 10 | KDR | 2.63593147 |
| 11 | TESK1 | 2.36556300 |
| 12 | MST1R | 2.34784677 |
| 13 | TESK2 | 2.19338753 |
| 14 | NME1 | 2.16152924 |
| 15 | TRIB3 | 2.10157365 |
| 16 | BUB1 | 2.06075572 |
| 17 | MAP2K2 | 1.97997624 |
| 18 | MYLK | 1.79615948 |
| 19 | EIF2AK1 | 1.75598805 |
| 20 | LRRK2 | 1.53620182 |
| 21 | GRK6 | 1.49514871 |
| 22 | ABL2 | 1.46720869 |
| 23 | LIMK1 | 1.41940157 |
| 24 | MST4 | 1.39759678 |
| 25 | IKBKE | 1.39121097 |
| 26 | MAP3K3 | 1.37681031 |
| 27 | PIK3CA | 1.36149644 |
| 28 | PRKD3 | 1.30724324 |
| 29 | DAPK3 | 1.30320283 |
| 30 | DAPK1 | 1.29635463 |
| 31 | PKN2 | 1.29599056 |
| 32 | FGFR4 | 1.28416506 |
| 33 | ILK | 1.27915260 |
| 34 | BRAF | 1.27536752 |
| 35 | TAOK1 | 1.21666326 |
| 36 | TYK2 | 1.21331543 |
| 37 | MAP2K3 | 1.20998399 |
| 38 | BLK | 1.20962041 |
| 39 | EPHA2 | 1.20240888 |
| 40 | MAP4K1 | 1.19761558 |
| 41 | TLK1 | 1.15442451 |
| 42 | EPHB2 | 1.15074439 |
| 43 | LMTK2 | 1.14805316 |
| 44 | ZAP70 | 1.13932969 |
| 45 | PRPF4B | 1.11653445 |
| 46 | TAF1 | 1.09667705 |
| 47 | PBK | 1.09086589 |
| 48 | KSR2 | 1.03952910 |
| 49 | STK16 | 0.94969659 |
| 50 | MAPKAPK3 | 0.91654274 |
| 51 | PAK4 | 0.91257523 |
| 52 | IRAK3 | 0.90377082 |
| 53 | IKBKB | 0.89955203 |
| 54 | ICK | 0.89257252 |
| 55 | MAP3K12 | 0.85925496 |
| 56 | MAP2K1 | 0.85792353 |
| 57 | TAOK2 | 0.83609640 |
| 58 | MAP3K8 | 0.81577057 |
| 59 | MAP3K14 | 0.78875648 |
| 60 | GRK5 | 0.78669427 |
| 61 | BRSK1 | 0.78160614 |
| 62 | PRKG2 | 0.76372456 |
| 63 | RPS6KA4 | 0.74513550 |
| 64 | NEK1 | 0.73552174 |
| 65 | MAP3K10 | 0.70186849 |
| 66 | SCYL2 | 0.69755952 |
| 67 | WNK4 | 0.69496058 |
| 68 | SIK1 | 0.69002819 |
| 69 | CDK11A | 0.67388123 |
| 70 | MAP2K6 | 0.66984283 |
| 71 | CDK19 | 0.66503546 |
| 72 | PDK2 | 0.64891356 |
| 73 | MAP3K1 | 0.64311042 |
| 74 | MAPK11 | 0.64222806 |
| 75 | EEF2K | 0.61722317 |
| 76 | RIPK1 | 0.60267691 |
| 77 | CAMK2G | 0.59408655 |
| 78 | PAK1 | 0.58129210 |
| 79 | CDK14 | 0.58019261 |
| 80 | CDK15 | 0.57846703 |
| 81 | TTN | 0.57622238 |
| 82 | PDK3 | 0.57509199 |
| 83 | PDK4 | 0.57509199 |
| 84 | AKT2 | 0.57078440 |
| 85 | NEK9 | 0.57014011 |
| 86 | RPS6KB2 | 0.56565603 |
| 87 | PIM1 | 0.56245064 |
| 88 | MAP3K2 | 0.55633634 |
| 89 | TAOK3 | 0.55531498 |
| 90 | CDC7 | 0.55460346 |
| 91 | WEE1 | 0.55151442 |
| 92 | CDK7 | 0.53843476 |
| 93 | CAMKK1 | 0.53721916 |
| 94 | AURKA | 0.52943408 |
| 95 | VRK1 | 0.52321001 |
| 96 | MAPKAPK5 | 0.52227752 |
| 97 | PIK3CG | 0.50875364 |
| 98 | PDPK1 | 0.50726919 |
| 99 | CSNK1G3 | 0.50606733 |
| 100 | CDK18 | 0.49831597 |
| 101 | CSNK2A2 | 0.49733013 |
| 102 | MUSK | 0.48606429 |
| 103 | OBSCN | 0.47442139 |
| 104 | MET | 0.45651488 |
| 105 | DYRK1B | 0.44891251 |
| 106 | PRKCI | 0.44381138 |
| 107 | PTK6 | 0.42126050 |
| 108 | AURKB | 0.40996094 |
| 109 | EIF2AK3 | 0.40517297 |
| 110 | MAP3K5 | 0.40380900 |
| 111 | MAPK12 | 0.39514475 |
| 112 | SIK2 | 0.39299562 |
| 113 | PINK1 | 0.39055588 |
| 114 | MAPK4 | 0.38385779 |
| 115 | PTK2 | 0.37469969 |
| 116 | PRKCD | 0.37289748 |
| 117 | RPS6KA2 | 0.36950778 |
| 118 | PRKD2 | 0.36700162 |
| 119 | DYRK3 | 0.34240588 |
| 120 | JAK2 | 0.34011953 |
| 121 | CSNK2A1 | 0.33993278 |
| 122 | NLK | 0.31709469 |
| 123 | MAPKAPK2 | 0.31445460 |
| 124 | DYRK2 | 0.30852049 |
| 125 | RPS6KA5 | 0.30469371 |
| 126 | CAMK2D | 0.28646295 |
| 127 | CAMK2B | 0.27616452 |
| 128 | RPS6KL1 | 0.27490256 |
| 129 | RPS6KC1 | 0.27490256 |
| 130 | RPS6KA1 | 0.27147122 |
| 131 | SRPK1 | 0.27031785 |
| 132 | EPHB1 | 0.25929047 |
| 133 | PRKCZ | 0.25922239 |
| 134 | TGFBR1 | 0.25637845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.94309743 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.67494837 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.64500622 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62886894 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.56441719 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.52962689 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52346548 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.32789110 |
| 9 | Sulfur relay system_Homo sapiens_hsa04122 | 2.21756399 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.19143579 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.12820704 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.04311855 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01539293 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.00824767 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.97981397 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94401910 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91319866 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83974819 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81518742 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.78275065 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76794545 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.74453078 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.70347252 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.68007635 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.67005450 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.64944929 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.61274319 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60936781 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60364795 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58113581 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55590611 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53246321 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50842597 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.45284031 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44910109 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44492285 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44201439 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43168268 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42058818 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41928346 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41718181 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40071524 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37903969 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.37019658 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35089397 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33303571 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31340289 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30054314 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.27033979 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25807858 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23145988 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22188945 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.19264362 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19132317 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 1.14827421 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09273894 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09267248 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06793954 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06311216 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05995756 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 1.05203832 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04451912 |
| 63 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.04433687 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04377276 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02366404 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99820999 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98215657 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.98203255 |
| 69 | Protein export_Homo sapiens_hsa03060 | 0.92168119 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91446784 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88924665 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87042526 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85778450 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85032839 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.82780637 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82663873 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81608116 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81092171 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78232419 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.75156739 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70030188 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68766404 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67440495 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64539031 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64468530 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.64006333 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62181380 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60908447 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57212914 |
| 90 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56894420 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56168026 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54687104 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.53546499 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.52840886 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44353626 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.43388319 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.37564451 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36451255 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.35091491 |
| 100 | Homologous recombination_Homo sapiens_hsa03440 | 0.30906001 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.29382448 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26461718 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26457763 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26315597 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24016096 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22808698 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.20895689 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20617933 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19958699 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.19651524 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.18015551 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.17787161 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16734775 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.16560847 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.16554979 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14836012 |
| 117 | DNA replication_Homo sapiens_hsa03030 | 0.14332645 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.14154493 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.13870284 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.13859843 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12563740 |
| 122 | Purine metabolism_Homo sapiens_hsa00230 | 0.12173182 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11743318 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10549441 |
| 125 | Asthma_Homo sapiens_hsa05310 | 0.09884066 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.08923020 |
| 127 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.07264302 |

